“…Cell replacement therapy using autologous or allogeneic adult limbal grafts has been the standard treatment for patients with severe limbal stem cell deficiency (LSCD) (Rama et al, 2010;Sangwan et al, 2011;Basu et al, 2016). However, in the case of bilateral epithelial defects and for the treatment of conditions affecting the stromal and endothelial cell layers, alternative stem cell sources such as embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) have been explored with a view to generating the various corneal cell types (Ahmad et al, 2007;Shalom-Feuerstein et al, 2012;Hayashi et al, 2012;Sareen et al, 2014;Mikhailova et al, 2014;Chan et al, 2013;Zhang et al, 2014;Chen et al, 2015;McCabe et al, 2015).…”